Nervonik is a healthcare startup focused on creating miniaturized neuromodulation devices aimed at treating chronic neuropathic pain. Its breakthrough technology targets the peripheral nervous system (PNS) using small, power-efficient implants that deliver electrical stimulation directly to affected nerves. These implants offer a narcotic-free long-term solution for patients suffering from various types of chronic pain, including shoulder pain, carpal tunnel syndrome, chronic headaches, and more. Currently available for research purposes, Nervonik is actively working towards FDA approval. The technology features wireless power transfer and is designed for minimally invasive outpatient procedures, enhancing recovery times and care efficiency. A digital app is provided to users for remote monitoring and adjustment of the device settings.